002675.SZ
东诚药业
SZSE · Healthcare · C 制造业 · CN
CNY 12.77
−2.07%Margins
Gross margin
52.9%
EBITDA margin
15.5%
EBIT margin
8.4%
Net margin
7.6%
FCF margin
2.7%
4.8%
Return on equity
2.2%
Return on assets
4.5%
Return on invested capital
0.29x
Asset turnover
CNY 434.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026